Customer Service:
Mon - Fri: 8:30 am - 6 pm EST

 Most recent

ISO/TR 37137:2014

Cardiovascular biological evaluation of medical devices - Guidance for absorbable implants

The objective of ISO/TR 37137:2014 is to provide interim Part-by-Part guidance on potential adjustments to various test methods within the 10993 series to account for the intentional release of soluble components or degradation products from absorbable medical devices. The content is intended to add clarity and present potentially acceptable approaches for reducing the possibility of erroneous or misleading results due to the nature of the absorbable material. All suggestions should be considered as preliminary and subject to change, with final dispositions implemented through direct modification to the respective parts of ISO 10993. Thus, interim adoption of any of the described adjustments requires an accompanying written justification.


Content Provider
International Organization for Standardization [iso]


Others Also Bought

Biological evaluation of medical devices—Part 6: Tests for local effects after implantation
Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and le ...
Biological evaluation of medical devices - Application of the threshold of toxicological concern (TTC) for assessing ...
Document History
We have no document history for this standard.
Included in Packages
This standard is not included in any packages.
Amendments & Corrections
We have no amendments or corrections for this standard.
ANSI Logo

As the voice of the U.S. standards and conformity assessment system, the American National Standards Institute (ANSI) empowers its members and constituents to strengthen the U.S. marketplace position in the global economy while helping to assure the safety and health of consumers and the protection of the environment.

CUSTOMER SERVICE
NEW YORK OFFICE
ANSI HEADQUARTERS